Viewing Study NCT01161550


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2025-12-28 @ 11:52 AM
Study NCT ID: NCT01161550
Status: COMPLETED
Last Update Posted: 2013-07-23
First Post: 2010-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module